Next working day delivery
When you order before midday (Terms apply)
Free UK delivery
When you spend £500 or more (Terms apply)
Training available
Nationwide
Novaclinical
The 4PLUS RF device is a revolutionary clinically proven skin tightening and fractional resurfacing system that instantly improves the appearance of the skin.
Made in Italy by Novavision, an innovative medical device engineering firm that provides all their own R&D and manufacturing onsite in Milan. Eden Aesthetics is the exclusive distributor of the 4PLUS in the UK and Ireland.
The 4PLUS includes 5 handpieces: face, eye/lip, fractional (non-invasive), large body and small body.
The 4PLUS boasts the following patented technology:
- DQRF: Dynamic Quadripolar RadioFrequency energy – as opposed to traditional monopolar or biopolar RF, with our DQRF, there are 4 poles (3 emitters and 1 receiver), that switch energy back and forth throughout the treatment, which creates a dynamic cloud of energy underneath the tissue for deep subdermal heating without overheating the surface of the skin. Thus, the client receives a minimally invasive, yet clinically significant, tightening and lifting result whilst receiving a comfortable, no downtime treatment.
- UPR: Ultra Pulsed Radioporation: nano-pulses of RF energy facilitate transmission of tailored active serums underneath the skin, providing the benefits of mesotherapy without needles. This technology is exclusive to the 4PLUS and offers 4 targeted serums to advance your clients’ results: Lift and Rejuvenate, Moisturise and Soothe, Lighten and Brighten, and Lipodissolve (fat-melting).
- The 4PLUS delivers focused energy to selected layers (epidermis, dermis, subcutis) and can be used for: face lifting & contouring (including submental sculpting with the lipodissolve serum), periorbital rejuvenation and brow lifts, lip smoothing and plumping, fractional resurfacing including fine lines, wrinkles and even stretch marks, body reshaping & contouring, cellulite reduction, skin tightening, hand and neck rejuvenation.